People

Prof. Quentin Liu is the Principal Investigator (PI) of the LiuQLab and a doctoral supervisor at Dalian Medical University, a Changjiang Scholar, Chief Scientist of a National 973 Program, recipient of the National Science Fund for Distinguished Young Scholars, and Fellow of the American Institute for Medical and Biological Engineering (AIMBE). His laboratory works at the interface of molecular targeted therapy, cancer stem-cell signaling, and neuro-immune regulation of cancer. He has published over 120 papers in journals including Nature Medicine, Nature Structural & Molecular Biology, Cancer Cell, Cell Metabolism, Cell Research, Journal of Clinical Oncology, and Signal Transduction & Targeted Therapy.